CannTrust Holdings
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Fluent Corp. earns a Neutral rating with 3/5 conviction, anchored by a composite score near 36. Regulatory is the strongest pillar at 49, supported by a 50 jurisdiction posture and an 80 enforcement subscore, with no enforcement hits recorded. Market contributes 40, although the absence of an available quote limits confirmation from institutional pricing feeds. Editorial contributes 30, reflecting no identified newsroom or brief activity in CIN newsroom coverage. Fundamentals rank last at 26, constrained by weak growth, negative profitability, a low market-cap tier, and limited cash-runway support. The pillar mix places Fluent in the Neutral band: the regulatory profile provides stability, while operating performance and stretched financial condition prevent a stronger rating.
Licensed fundamentals data show year-over-year revenue contracting by roughly 22%. Gross margin stands near 19.5%, offering insufficient support against an operating margin of approximately negative 46%. Net income was a loss approaching $79 million, while EBITDA was also negative at nearly $16 million, confirming that the pressure extends beyond noncash and below-the-line items. Market capitalization is approximately $13.4 million, corresponding with a market-cap subscore near 5, and the cash-burn ratio is about 1.18. Cash runway contributes only 15 to the fundamentals assessment, consistent with the stated stretched condition. Primary regulatory filings provide no latest filing date, producing a cadence subscore of 25. No regulatory events were captured over either the latest 90-day or 180-day periods, leaving the regulatory score driven chiefly by jurisdiction posture and the clean enforcement record rather than active filing momentum.
The clearest rerating catalyst sits within the strongest pillar: restoration of a visible, consistent primary-filing cadence. A current filing would strengthen the weakest component inside regulatory, improve transparency around the severe revenue decline and operating losses, and provide a firmer basis for assessing the stretched financial position. The clean enforcement record already supplies the pillar’s principal support, but cadence now determines whether regulatory quality can translate into higher conviction. The single most important signal to watch is the appearance of a current primary regulatory filing that re-establishes consistent disclosure cadence.
- Headquarters
- 5540 W. EXECUTIVE DRIVE, TAMPA, FL, 33609
- Phone
- 8884415669
- SEC CIK
- 1758124
- Website
- Company website
- Market cap
- $13.4M
- Enterprise value
- $157.3M
- Price to book
- 8.65
- Price to sales
- 0.16
- EV / EBITDA
- 3.63
- Revenue (TTM)
- $81.7M
- Gross profit (TTM)
- $15.9M
- EBITDA
- $-15.8M
- Operating margin
- -46.0%
- Profit margin
- -96.3%
- Rev growth YoY
- -21.9%
- Return on equity
- -534.2%
- Return on assets
- -10.3%
- EPS (TTM)
- $-0.16
- Wall St. target price
- $1.70
- Shares outstanding
- 613.3M
- Insider ownership
- 36.9%
- Institutional ownership
- 1.9%
- Beta
- 0.76
- Full-time employees
- 826
- GICS sector
- Healthcare
- GICS industry
- Drug Manufacturers - Specialty & Generic
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for CannTrust Holdings (CNTMF)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for CannTrust Holdings (CNTMF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for CNTMF are maintained by Cannabis Investor News and refreshed throughout the trading day.